Thank you for your interest in clinical trials for Polycythemia VeraPlease click "Search" to find Polycythemia Vera clinical trials and medical research studies.If you receive too many study listings you may enter your zip code to find the locations closest to you.
Your search returned no results. Get alerts when studies become available.
Your search returned 16 studies. (Get alerts for new studies):Familial Myeloproliferative DisordersConditions: Polycythemia Vera - Essential Thrombocythemia - Idiopathic Myelofibrosis5 Locations availableRuxolitinib (INCB018424) in Subjects With Primary Myelofibrosis, Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosisConditions: Primary Myelofibrosis - Post Essential Thrombocythemia-myelofibrosis - Post Polycythemia Vera-myelofibrosis21 Locations availableRuxolitinib Prior to Transplant in Patients With MyelofibrosisConditions: Primary Myelofibrosis - Post Polycythemia Vera Myelofibrosis - Post Essential Thrombocythemia Myelofibrosis7 Locations availableEfficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis (MF), Post-polycythemia Vera MConditions: Primary Myelofibrosis (PMF), - Post-polycythemia Vera (Post-PV) - Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)11 Locations availableCorrelative Biomarker Study in Patients With Myeloproliferative DisordersConditions: Myeloproliferative Disease - Myelofibrosis - Idiopathic Myelofibrosis - Essential Thrombocythemia - Polycythemia Vera15 Locations availableMomelotinib Versus Ruxolitinib in Subjects With MyelofibrosisConditions: Primary Myelofibrosis - Post-Polycythemia Vera Myelofibrosis - Post-Essential Thrombocythemia Myelofibrosis12 Locations availableResearch Tissue BankConditions: Myelofibrosis - Idiopathic Myelofibrosis - Essential Thrombocythemia - Polycythemia Vera9 Locations availablePegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET)Conditions: High Risk Polycythemia Vera - High Risk Essential Thrombocythemia13 Locations availableA Phase 2 Study Of PRM-151 In Subjects With MyelofibrosisConditions: Primary Myelofibrosis - Post-Polycythemia Vera Myelofibrosis - Post-Essential Thrombocythemia Myelofibrosis5 Locations availableOral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With ThrombocytopeniaConditions: Primary Myelofibrosis - Post-polycythemia Vera Myelofibrosis - Post-essential Thrombocythemia Myelofibrosis38 Locations availableRandomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)Conditions: High Risk Polycythemia Vera - High Risk Essential Thrombocythemia13 Locations availableTissue Banking Study - Polycythemia Vera or Essential Thrombocythemia (PV & ET) PatientsConditions: Polycythemia Vera - Essential Thrombocythemia1 Location availablePhase 2 LCL-161 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF) or Post-Essential Thrombocytosis MyeloConditions: Leukemia1 Location availableProspective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)Conditions: Polycythemia Vera157 Locations availableSafety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia Conditions: Primary Myelofibrosis - Post-Polycythemic Vera Myelofibrosis - Post-Essential Thrombocythemia Myelofibrosis8 Locations availableOpen Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential ThrombocythemiaConditions: Polycythemia Vera - Essential Thrombocythemia1 Location available
Didn't find what you were looking for? Try these alternatives:
ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.
ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.